American Society of Hirudotherapy

Compromised breast flap treated with leech therapy, hyperbaric oxygen, pentoxifylline and topical nitroglycerin: A case report

Case report published in Undersea Hyperb Med (2015)

Last Updated: November 1, 2026ASH Editorial · based on the books
Research article — evidence review: Off-label use means application outside the FDA-cleared indication. Clinical evidence (RCTs or systematic reviews) supports this use, but the FDA has not cleared it.Article reference: Content describes science, methodology, or organizational reference material — not a clinical efficacy claim.
Evidence: Case reportClinical LiteratureSafety & Infection ControlMoffat AD et al. · Undersea & hyperbaric medicine, 2015

Abstract

INTRODUCTION: Hyperbaric oxygen (HBO2) is often indicated in compromised surgical flaps. Although limited to animal models and human case reports, the utilization of leech therapy (Hirudo medicinalis) with HBO2 provides better outcomes than each modality alone. Topical nitroglycerin and pentoxifylline are also frequently used adjunctively for compromised flaps. We present a case of successful breast flap salvage utilizing a combination of leech therapy, HBO2, topical nitroglycerin and pentoxifylline. CASE REPORT: A 34-year-old female, one day post-status cosmetic breast reduction mammoplasty developed a dusky discoloration of the left nipple areolar complex, indicating imminent flap failure. The patient was immediately treated with topical nitroglycerin, oral pentoxifylline, and referred for HBO2. After her first HBO2 treatment, there was clinical improvement to the superior portion of the areolar flap, with little improvement inferiorly where the discoloration had remained essentially unchanged. To address this, we added leech therapy and discontinued the topical nitroglycerin. Ceftriaxone for Aeromonas prophylaxis was started, and leeches were attached two at a time and removed from the area once feeding had ceased. These were applied three times per day for three days while receiving HBO2 twice per day for six days. The patient's flap improved and completely healed by Week 8 without need for further surgery. CONCLUSION: This is the first case to our knowledge of successful breast flap salvage using a combination of leech therapy, HBO2, topical nitroglycerin and pentoxifylline.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeCase ReportsJournal Article
Indexed MeSH termsAdultAnimalsAnti-Bacterial AgentsCeftriaxoneCombined Modality TherapyFemaleGraft SurvivalHumansHyperbaric OxygenationLeechingMammaplastyNipplesNitroglycerinPentoxifyllinePigmentation DisordersSalvage TherapySurgical FlapsVasodilator Agents

Summary

In a 34-year-old woman, a compromised nipple-areolar flap after cosmetic breast reduction was salvaged without further surgery using leech therapy (Hirudo medicinalis) combined with hyperbaric oxygen, pentoxifylline and topical nitroglycerin; it healed completely by week 8.

Why This Matters for Hirudotherapy

This case report describes a 34-year-old female who developed dusky discoloration of the left nipple-areolar complex one day after cosmetic breast reduction mammoplasty, indicating imminent flap failure. She was treated with a combination of leech therapy (Hirudo medicinalis, two leeches at a time, three times per day for three days), hyperbaric oxygen, pentoxifylline, and initial topical nitroglycerin, with ceftriaxone started for Aeromonas prophylaxis; the flap completely healed by week 8 without further surgery. This case documents hirudotherapy used adjunctively for compromised breast flap salvage, with explicit attention to Aeromonas prophylaxis. The clear limitation is that this is a single case report with no control group and combination therapy, so no causal attribution to leech therapy alone or generalizability can be claimed.

Citation

Reference (Vancouver style)

Moffat AD, Weaver LK, Tettelbach WH. Compromised breast flap treated with leech therapy, hyperbaric oxygen, pentoxifylline and topical nitroglycerin: A case report. Undersea Hyperb Med. 2015;42(3):281-284. PMID: 26152110

Bibliographic details (authors, volume, pages, DOI) are taken from the PubMed record.

Added to ASH library: May 27, 2026 · Site last updated: November 1, 2026

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.